glp-1 bulimia Receptor Agonists and Research to Treat Overeating and Substance Use Disorders GLP-1 obesity drugs and eating

What Ongoing Research May Clarify A PL 14736 trial (PL 14736 is the pharmaceutical-grade formulation of BPC-157 developed for clinical investigation) was listed on ClinicalTrials.gov for inflammatory bowel disease, though results have not been published as of May 2026 15

If you find that your morning is too chaotic or that you prefer a nighttime "wind-down" routine, taking them before bed is significantly better than not taking them at all

The EMPA-REG OUTCOME trial was a long-term, multicenter, randomized, double-blind, placebo-controlled trial of more than 7,000 patients from 42 countries with type 2 diabetes at high risk for cardiovascular events

According to research, reducing just 12% of body fat can increase a persons lifespan by 6.8 years